RTW INVESTMENTS, LP Q1 2018 Filing
Filed May 14, 2018
Portfolio Value
$1.1T
Holdings
38
Report Date
Q1 2018
Filing Type
13F-HR
All Holdings (38 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | RCKTRocket Pharmaceuticals Inc | 14,969,744 | $258.2B | 24.57% | |
| 2 | PTCTPTC Therapeutics Inc | 4,137,960 | $112.0B | 10.66% | |
| 3 | BMYBRISTOL MYERS SQUIBB CO | 1,096,386 | $69.3B | 6.60% | |
| 4 | RGNXRegenxbio Inc | 1,877,767 | $56.1B | 5.33% | |
| 5 | SRPTSarepta Therapeutics Inc | 688,271 | $51.0B | 4.85% | |
| 6 | —ACHILLION PHARMACEUTICALS IN | 13,496,902 | $50.1B | 4.77% | |
| 7 | —Dicerna Pharmaceuticals Inc | 5,029,462 | $48.1B | 4.58% | |
| 8 | AGENEURAgenus Inc | 9,313,556 | $43.9B | 4.17% | |
| 9 | —La Jolla Pharmaceutical Co | 1,122,540 | $33.4B | 3.18% | |
| 10 | ALNYAlnylam Pharmaceuticals Inc | 246,229 | $29.3B | 2.79% | |
| 11 | —Avexis Inc | 236,425 | $29.2B | 2.78% | |
| 12 | I9DNArbutus Biopharma Corp | 5,151,615 | $25.8B | 2.45% | |
| 13 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 456,921 | $22.1B | 2.10% | |
| 14 | —CORIUM INTL INC | 1,910,522 | $21.9B | 2.09% | |
| 15 | ARWRARROWHEAD PHARMACEUTICALS IN | 2,916,561 | $21.0B | 2.00% | |
| 16 | VCELVericel Corp | 2,067,916 | $20.6B | 1.96% | |
| 17 | 3M4Masimo Corp | 232,000 | $20.4B | 1.94% | |
| 18 | EWEdwards Lifesciences Corp | 145,246 | $20.3B | 1.93% | |
| 19 | —Armo Biosciences Inc | 413,892 | $14.0B | 1.33% | |
| 20 | —Myokardia Inc | 259,670 | $12.7B | 1.21% | |
| 21 | LIVNLivaNova PLC | 140,000 | $12.4B | 1.18% | |
| 22 | QUREUniqure NV | 406,667 | $9.6B | 0.91% | |
| 23 | —VIVEVE MED INC | 2,557,559 | $9.4B | 0.89% | |
| 24 | VRAYQViewray Inc | 1,358,711 | $8.7B | 0.83% | |
| 25 | —Nuvectra Corp | 507,061 | $6.6B | 0.63% | |
| 26 | —Bovie Medical Corp | 1,931,948 | $5.7B | 0.55% | |
| 27 | NVAXNovavax Inc | 2,726,504 | $5.7B | 0.54% | |
| 28 | —Odonate Therapeutics Inc | 274,544 | $5.3B | 0.50% | |
| 29 | —PROTEOSTASIS THERAPEUTICS IN | 1,104,940 | $5.2B | 0.50% | |
| 30 | SLDBSolid Biosciences Inc | 675,771 | $4.6B | 0.44% | |
| 31 | CDNACareDx Inc | 560,600 | $4.5B | 0.43% | |
| 32 | FIXXEURHomology Medicines Inc | 225,000 | $4.2B | 0.40% | |
| 33 | —VIVUS INC | 4,000,000 | $2.5B | 0.24% | |
| 34 | ARGXARGENX SE | 25,457 | $2.0B | 0.19% | |
| 35 | EP3OraSure Technologies Inc | 117,291 | $2.0B | 0.19% | |
| 36 | —Novus Therapeutics Inc | 300,000 | $1.5B | 0.14% | |
| 37 | ADVMCHFAdverum Biotechnologies Inc | 175,208 | $1.0B | 0.10% | |
| 38 | —MOTUS GI HLDGS INC | 118,478 | $531.0M | 0.05% |